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I. Introduction and Review of Relevant Literature
  
 Over 400 million people worldwide suffer from bladder diseases1.  Bladders are 
ravaged by cancer, birth defects, nerve damage, or trauma.  When conservative therapies 
are ineffective, bladder augmentation or urinary diversion are recommended as 
alternative therapies 2.  In worst cases, patients can require extensive surgery or bladder 
transplants.  Today, enterocystoplasty is the most utilized method for bladder 
augmentation using ileum, colon, or stomach segments 3.  In this technique a section of 
the patient’s own stomach or intestine is used to patch the bladder wall   This technique 
can lead to malnutrition, electrolyte alterations, peritoneal adherences, abscesses, enteric 
fistulae, excessive mucus production, bacterial colonization, and cancer 4.  In addition to 
the shortage of available organ and tissue donors there are other disadvantages associated 
with autografts, tissues taken from the patient, include complications such as the 
formation of bladder stones.  The risk of complications rises when using allografts, 
tissues taken from human donors. Additionally, there is a risk of hyperacute rejection due 
to potential mismatch of xenografts, tissues taken from an animal source.  These 
obstacles show the need for alternative repair options.  Tissue engineering  has been used 
in order to minimize these complications, and a variety of natural or synthetic materials 





 The basic approach of tissue engineering uses biodegradable scaffolds to support 
and guide the in-growth of cells (Figure 1.)   Tissue scaffolds must be biodegradable, 
bioresorbable, biocompatible, and sterilizable.  The scaffold must provide enough 
mechanical strength to withstand physiological stresses, must provide an environment 
suitable for cellular growth, and should contain suitable surface properties (wettability, 
stiffness, and compliance) to support cell attachment, proliferation, and differentiation. 
Eventually, the scaffold material disappears leaving only normal healthy tissue6-8.  
Additionally, the degradation products should be biocompatible, non-toxic, and 










Figure 1. Concept of Tissue Engineering 
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 Currently, there are two tissue engineering methodologies, “unseeded” and 
“seeded”.  The unseeded techniques involve the direct in vivo implantation of a 
biodegradable scaffold into the host bladder, allowing the natural process of regeneration 
to occur.  In contrast, seeded techniques utilize in vitro cell culture of primary bladder 
cells, derived from host’s tissue, on biodegradable scaffolds to establish cell-composite 
grafts, followed by in vivo implantation of the grafts.  Scaffolds generated from natural 
polymers 9, synthetic polymers, or by removing the cellular components from xenogeneic 
tissues 1 have been used with and without prior cell-seeding to support and guide the in-
growth of cells.   
Natural Matrices  
 One option for creating tissue scaffolds is to use extracellular matrix (ECM) 
components derived from animal sources.  For example porcine acellular dermis has been 
used for skin regeneration10 and control of hypertrophic scarring 11.  Small intestinal 
submucosa (SIS) i another material that has shown significant success in various tissue 
engineering applications12.  SIS is a dense connective tissue harvested from the small 
intestine.  SIS is obtained after removing the mucosa, serosa, and muscle layers from the 






Figure 2.  Layers within the Small Intestine 
 
 Porcine SIS has generated immense interest in various tissue engineering 
applications due to its diverse favorable properties 13,14.  SIS is the only bio-material that 
does not require cell seeding prior to in vivo implantation for bladder regeneration.  SIS 
is rich in type 1 collagen, biocompatible, pliable, and resistant to infection.  Additionally, 
SIS has a resorption rate of 4-16 weeks 15,16 and its immune response shows a phenotypic 
characteristic of tissue remodeling rather than rejection 17.   SIS promotes cell migration 
of numerous cell types and has been tested for regeneration of diverse tissues including 
large vascular grafts 18, venous valves and leaflets 19-21, skin 22, tendons 23, and wound 
dressing 24.  For urinary tract reconstruction, SIS has been used for bladder augmentation 
25-27, for ureter 28 and urethra 25,29 replacement, and to promote regeneration of 
transitional epithelium, smooth muscle, and peripheral nerves with no evidence of 
immunological rejection 30.  Long-term studies show that SIS grafts can be remolded and 
replaced by the host and such regenerated tissues become histologically indistinguishable 
from native tissues 26.  The remodeled tissue shows complete regeneration of all three 
layers (mucosa, smooth muscle, and serosa) of the bladder in rat 31 and dog 32,33 models 






Additionally, SIS is commercially from a number of sources.  COOK Biotechnlogy 
(West Lafayette, IN) sells single ply porcine SIS under the trade name Surgisis® at a cost 
of $286 per 7 cm x 10 cm sample34. COOK also sells multiply Surgisis® SIS, but 
multiply SIS does not provide reliable bladder regeneration compared to single ply SIS35.   
 Large-scale preparation of SIS is hindered by various physiochemical properties 
which affect the quality and reliability of the tissue regeneration in clinical settings.  The 
physical and mechanical characteristics of the matrix, such as permeability, thickness, 
tensile properties, fatigue properties, and ultrastructural properties, vary depending on the 
age of the animal, the sterilization technique, and the location within the small intestine it 
is harvested from 36.    
 Relative to home-made proximal SIS and COOK SIS, home-made distal SIS has 
the lowest permeability.  COOK SIS (single ply) has the lowest tensile load bearing 
capacity relative to distal and proximal SIS.  E-beam sterilization resulted in severe 
contraction and bone formation within the graft which was not observed after ethylene 
oxide sterilization35.  Nevertheless, in a canine model study, bladder augmentation with 
distal SIS showed remarkably enhanced bladder regeneration relative to proximal SIS 37.  
Further, SIS obtained from the distal region (Figure 3) of the intestine enables better 
cellular ingrowth and tissue remodeling than SIS taken from the proximal region 35.  Thus, 
forming synthetic matrices with physiochemical properties similar to distal SIS will be 
useful in bladder and other soft tissue regeneration.   
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Figure 3. Location of the Submucosa within the Small Intestine 
   
Formation of Three Dimensional Polymer Scaffolds  
 An alterative to using natural matrices is to synthesize polymer matrices for use as 
tissue engineering scaffolds. Both natural and synthetic polymers have been used in 
tissue engineering applications.  It is also important to include a three dimensional porous 
structure into the scaffolds to promote cellular ingrowth and differentiation 38. 
 Several techniques have been developed to fabricate porous scaffolds, including 
solvent casting/particulate leaching 39, fiber bonding (unwoven meshes) 40, gas foaming 41, 

















to introduce a porogen such as salt (NaCl) into the polymer and then remove it with a 
solvent (particulate leaching) 43.  The leaching of salt from a polymer composite can form 
pores within scaffolds, the pore sizes are dependent on the size and amount of salt 
crystals.  Pore size and distribution is difficult to control.  Gas porogen has been used as 
alternative to eliminate the use of organic solvents (gas foaming).  But the pores created 
in this method are non-uniform, limiting cell seeding and migration 40.   
Scaffolds can be formed using 3D printing techniques.  Scaffolds are built layer 
by layer, and the pore size and spacing are controlled by the pattern used. The advantage 
to 3D printing is the control of pore size and distribution. The disadvantage is that the 
fiber diameter limits the pore sizes and configurations possible.  Currently, construction 
is limited to a 150 m fiber diameter 44.  Direct writing processes are also limited by the 
ink used.  To assure successful printing the ink must be viscous enough to holds its shape 
after printing but not so viscous that it is too difficult to pump.  Additionally the ink must 
quickly form the polymer fiber after printing, as well as bond to previously printed layers.      
3D porous scaffolds can also be created using standard microfabrication 
techniques including microembossing45 and soft lithography46,47.   Microfabricated 
scaffolds can be produced that contain both pores and nano-scale surface features, 
enabling better control of the cellular microenvironment. 
Scaffolds with nanofibers can be produced using electrospinning process48,49,50.   
In the process of electrospinning a non-woven matrix is formed by directing a charged 
polymer solution at an oppositely charged collector.  Additionally, changing the 
orientation of the collector can produce both random and aligned nanofibers 
arrangements. 
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Three dimensional scaffolds can also be formed using hydrogels, water soluble 
polymers crosslinked into a 3D matrix51.  One of the prime advantages to hydrogels is 
that they can be polymerized in situ by thermo-gelling52 or photocrosslinking 53,54.  
Another advantage is that cells can be encapsulated directly into the scaffold, providing 
faster tissue ingrowth.  In autoimmune disorders, like diabetes, hydrogels can serve as a 
protective barrier between the implanted functional cells and the immune system 55. 
 Due to a number of advantages this study used controlled rate freezing and 
lyophilization  to create the porous chitosan structures 56.  By controlling the rate of 
freezing, ice crystals form in the solution following the path of heat flow.  While the 
solution freezes the polymer precipitates out of solution and is trapped between the ice 
crystals.  The solvent is then removed by freeze drying, leaving the porous polymer 
structure intact.  The pore size is determined by the size of the ice crystals.  Therefore, the 
size and orientation of pores can be directed by controlling the rate and direction of 
freezing.  By freezing at a constant temperature the pore size becomes a function of 
freezer temperature; quicker freezing will produce smaller pores.  This process also 
avoids heat denaturation of biological materials because it is performed at low 
temperature.  This allows bioactive molecules to be included in the scaffold without 
altering their activity, if necessary. 
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Importance of 3D Architecture   
 Recent advances in tissue culture have shown that cells respond differently in 
attachment, morphology, migration and proliferation on a 3D scaffold then in traditional 
two-dimensional tissue culture38.  Many cell types such as fibroblasts, mesenchymal stem 
cells, epithelial cells, and neural crest cells show different adhesions when grown on 3D 
matrices as opposed to 2D cell culture 57,58.  In 2D substrata, cultured cells are restricted 
to spreading and attaching to a flat rigid glass or tissue culture plastic surface coated with 
different substrates.  The influence of biophysical properties of the material may be 
overwhelmed by the effect of the rigid surface.  However, biophysical properties 
significantly influence cell adhesion, signaling and functions in 3D environment.  Further, 
the 3D architecture could distribute binding sites differently than 2D architecture 57,59.  
3D focal adhesions appear distinct from 2D focal adhesions on a rigid 2D matrix and are 
termed as “3D matrix adhesions” to separate them from 2D counterparts.  In addition to 
proteins present in focal adhesions on 2D matrices, cells may have cytoskeletal adaptor 
proteins on 3D matrix 57,60.   Such discrepancy in cell adhesion between 2D vs. 3D causes 
different signal transduction, subsequent altered cell morphology and rearrangement.  In 
response to different physical and chemical signals from surrounding 3D matrix, cells can 
synthesize ECM components and the degradation of matrix can create spatial advantages 
for cell expansion and forward migration, unlike 2D architecture.  Pore size and void 
fraction 61-65, stiffness, pore interconnectivity, and topography66 can affect cell 
colonization in synthetic scaffolds.  A majority of the cells are unable to completely 
colonize scaffolds with pore sizes > 300 nm due to difficulty in crossing large bridging 
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distances61.  An optimum pore size range for many cell types is 100 – 150 nm.  Hence 
matrices with that pore size range are preferred in many applications.  
Synthetic Polyesters  
Synthetic polyesters such as poly (lactic acid) (PLA), poly (glycolic acid) (PGA), 
their copolymers (PLGA, PLLA, etc) 67-73, and poly (caprolactone) (PCL) 74,75 have 
generated immense interest as tissue engineering materials due to their strong approval 
history (few products are FDA approved) and numerous investigations in a variety of 
biological applications for more than three decades 76.  These polymers degrade by 
hydrolysis (i.e., non-enzymatically).  Their degradation rates and mechanical properties 
can be altered via co- and graft-polymerization techniques 77-79, and by processing 
conditions 80-83.   
PGA is a rigid thermoplastic material with high crystallinity and is hydrophilic 84.  
PLA is more hydrophobic than PGA due to an extra methyl group in the lactide molecule.  
Because lactic acid is a chiral molecule, PLA has D-PLA and L-PLA stereoisomeric 
forms.  Of the two isomers L-PLA is more frequently used in tissue engineering because 
it possesses high mechanical strength 85.  Poly (lactic-co-glycolic acid) (PLGA) is the 
copolymer of glycolic acid and lactic acid (Figure 4).  Various ratios (75 PLA:25 PGA, 
50:50, etc) of PLGA have been investigated.  Amorphous 50:50 PLGA (50% lactic acid, 
50% glycolic acid) is preferred for various tissue engineering applications because it 
degrades faster than other co-polymer ratios, which are semi-crystalline.  The degradation 
of PLGA is via random hydrolysis of the ester bonds.  In addition, the degradation rate 
can be modified by changing the copolymer ratio and molecular weight (lower molecular 
weights degrade faster) 86.   
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Figure 4. Chemical Structure of PLGA 
  
Poly (caprolactone) (PCL) is a non-toxic, biocompatible aliphatic polyester 86.  PCL 
has a degradation time dependent on its molecular weight.  High molecular weight 
degradation times are of the order of two to three years make which it unsuitable for short 
term implants 87.  The rate of degradation can be altered by copolymerization with other 
polymers.   
Poly (propylene fumarate) (PPF) based polymers have been developed as injectable 
materials for orthopedic applications 86.  PPF can be photo cross-linked with poly 
(propylene fumarate)-diacrylate (PPF-DA) by free radical polymerization to form solid 
polymeric networks with high compressive strength at a bone fracture site88.  The 
degradation of PPF produces fumaric acid and propylene glycol and the degradation time 
is dependent on the polymer structures.   
Synthetic polymers show poor regulation of cellular activity 89.  Furthermore, their 
degradation products are relatively strong acids and cause inflammation 90.  The scaffolds 
also show structural instability due to massive swelling during degradation 82.  Apart 
from adhesive interactions, a substrate has to mediate a variety of signals such as growth 
factor activity to regulate the biological response of diverse cell types.  Despite 
H ( O C CH ) 
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significant efforts to improve these limitations via co-polymerization 91 and grafting 
arginine-glycine-aspartate (RGD) peptides (necessary for cellular attachment) 92, 
recreating all the biological responses may be beyond current capabilities. 
Natural Polymers  
 Natural polymers are derived from a variety of sources including fish scales, rat 
tails, and crab shells.  Unlike synthetic polymers, natural polymers have superior 
biological properties.  However, natural polymers lack physical strength.  Porous 
scaffolds formed of natural polymers have a modulus of only 2 kPa, compared to 3 MPa 
for SIS. 
 Chitosan is a polysaccharide derived from N-deacetylation of chitin, a polymer 
present in the outer shells of crustaceans. Chitosan is composed of  (1-4) linked 2-
acetamido-2-deoxy-D-glucose and 2-amino-2-deoxy-D-glucose units (Figure 5).  It is a 
semi-crystalline polymer, and the crystallinity is dependent on the degree of deacetylation.  
Chitosan is structurally analogous to glycosaminoglycan (GAG), an extra cellular matrix 
(ECM) element present in the human body.  Since GAG has specific interactions with 
growth factors/proteins, chitosan may share similar activity.  Chitosan is insoluble in 
water or organic solvents but soluble in aqueous acids (pH< 6.3).  Due to the protonation 
of the free amine groups on the chain backbone (Figure 5), chitosan exhibits a high 
charge density in solution.  This cationic nature and high charge density allow favorable 
interactions with negatively charged cells as well as antibacterial activity.  Chitosan has 
been widely investigated in wound dressing  and drug delivery systems 93.  The 
biocompatibility and biodegradability of chitosan makes it a promising material for tissue 
engineering94.  Chitosan has shown biological activity towards diverse cell types 
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including stem cells95,96, chondrocytes96,97, osteoblasts97, hepatocytes78,98, and Schwann 
cells 99,100.  In addition, chitosan has minimal immune reaction and its stimulatory effect 
can induce local cell proliferation95.  Chitosan can be degraded by lysozyme, a naturally 
occurring enzyme in vivo56.  The biodegradation time is determined by the amount of 
residual acetyl content, an easily controlled variable.  Due to the active amino groups 
(Figure 5), chemical modification of chitosan can produce materials with a variety of 
physical and mechanical properties.  Polysaccharide scaffolds were synthesized by 
crosslinking arabinogalactan, dextran and amylose with chitosan to create a more cell 
compatible environment 101.  Chitosan is also blended with collagen, alginate, GAG, and 
synthetic polymers (i.e. PLGA, PCL) to fabricate suitable scaffolds 102.  The pH 
dependent solubility, the easy processability under mild conditions, the modification 
reactivity, the biodegradability, and biocompatibility make chitosan an excellent 
candidate for use as porous scaffolds in tissue engineering.    
 
Figure 5. Chemical Structure of Chitosan 
  
Hyaluronan, a large linear GAG, is composed of repeating disaccharide of D-N-
acetylglucos-amine--D-Glucuronic acid 103.  It is negatively charged, acts as a 
polyelectrolyte in solution, and acts as a lubricant 104.  Although hyaluronan is involved 












Collagens are a family of structural proteins reinforcing a variety of animal tissues 
including skin, bone, and tendon.  Type I collagen is a major component of most 
connective tissues and present in the arterial wall 85 and may be degraded by several 
matrix metalloprotenases (MMPs) 105.  Collagen contains cellular-binding domains and 
has been extensively used in vascular tissue engineering.   
Gelatin, a partially denatured derivative of collagen, has also been used to generate 
scaffolds.  Gelatin is widely found in nature, and can be extracted from collagen found in 
fish, bovine bone, and porcine skin.  The physicochemical properties of gelatin can be 
suitably modulated due to the existence of many functional groups.  Gelatin blended with 
chitosan has been used in artificial skin and cartilage applications due to the ability to 
form a polyelectrolyte complex 106,107.   
Fibrin has been used for cartilage repair 108.  Upon injury, fibrinogen self-assembles 
to become 3D fibrin hydrogel 84.  Fibrin can bind to different integrin receptors to 
regulate cytokine gene expression as well as regulate inflammation.  Since fibrinogen can 
be obtained from the patient’s own blood, use of fibrin minimizes immunogenic concerns.  
Another advantage of fibrin is that it can be degraded by cell-associated enzymatic 
system.  Despite these advantages, fibrin scaffolds failed to keep their shape integrity.  
Fibrin gels showed significant reduction in size after in vitro incubation and weak 
compression modulus 109, suggesting a need for further modifications.   
Polyhydroxyalkanoates are polyesters produced in microorganisms.  The molecular 
weight of these polymers can be tailored by varying bacterial strain and media 
composition 110.  Most of these homopolymers are highly crystalline, brittle and have a 
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very long degradation time (up to years).  Thus they are not suitable for scaffolding 
materials unless blended with other materials compensating for the disadvantages.    
Combining Natural and Synthetic Polymers  
 While natural materials have the benefits of facilitating cell adhesion and 
repopulation by providing critical signals, they lack tailorability of mechanical properties.  
In contrast, synthetic materials possess advantages of easy control of microstructure, 
strength and degradation rate, but they lack growth factors and other  signals to direct cell 
growth, proliferation, and differentiation 85.  Previous research has shown that it is 
possible to combine natural and synthetic polymers.  One method is to create an 
emulsification system111.  The emulsification system was required because there is no 
universal solvent for both hydrophilic natural polymer and hydrophobic synthetic 
polymers, and therefore, the polymers could not simply be blended.   
 Scaffolds were synthesized from the emulsions of the chitosan-PLGA blends 
(Figure 6A)111.  Cellular activity of enhanced green fluorescence protein (EGFP)-
transfected primary bladder- smooth muscle cells (SMC) was tested on these scaffolds.  
These results showed minimal cell spreading and proliferation on the scaffolds (Error! 
Reference source not found.B).  Recently, it was shown that the observed difference in 
these emulsions is due to structural weakness in the matrix and minimal electrostatic cell 
adhesion to chitosan95.  However, Figure 6C shows that the acidic degradation products 
of PLGA significantly influenced the degradation kinetics of lysozyme-dependent 
chitosan degradation.  Thus, the only benefit of the PLGA, chitosan emulsion was an 
increased degradation rate of chitosan.  Another problem with the emulsified scaffolds 
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was their lack of physical strength.  The emulsified scaffolds have a modulus of only 2 






Figure 6. Emulsified Chitosan-PLGA Scaffolds 
Panel A. 50:50 PLGA was blended with chitosan and matrices were formed using controlled rate 
freezing and lyophilization. Panel B. On to PLGA-chitosan matrix, GFP-transfected SMCs were 
seeded and micrographs were obtained after 4 days in culture. Panel C. Scaffolds were incubated in 
presence or absence of 10mg/L lysozyme.  Photographs taken after 24 days i) chitosan in PBS, and ii) 
chitosan-PLGA in PBS containing lysozyme 111. 
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II. Hypothesis  
 An alternative to uniformly blending natural and synthetic polymers is to form 
composite matrices where the strengths of each polymer can be exploited while its 
weaknesses are minimized.  Natural polymers (chitosan, gelatin, etc) have superior 
biological properties but degrade slowly and lack physical strength 95.  Synthetic 
polymers (PCL, PLA, PGA, PLGA, and others) have strength, elasticity, and tunable 
degradation properties but lack appropriate biological activity.  A composite material 
formed by layering 3D porous chitosan and PLGA films may provide the individual 
advantages of the pure polymer membranes while overcoming the limitations inherent in 
the polymer type.  
  In one possible composite configuration, the outer chitosan layers provide 
biological activity while the PLGA layer provides mechanical strength.  The difficulty 
inherent in creating a composite scaffold is attaching the hydrophobic PLGA layer to the 
hydrophilic chitosan layers.  A possible method to ensure connection between the layers 
is to perforate the PLGA film and have the porous chitosan run continuously through the 
perforations.  Hence, the main goal in this project is to develop a process to produce 
multi-layered composite scaffolds containing both natural and synthetic polymers. 
 Once the process is created the scaffolds should be characterized.  Therefore, the 
tensile properties, permeability to urea, degradation behavior, and cell culture behavior of 
the composite scaffold will also be tested.  The underlying goal is to produce a composite 
scaffold with physiochemical properties similar to distal SIS. 
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III. Materials and Methods 
Sources for Material  
 PLGA (50:50, molecular weight = 160 kDa) was purchased from Birmingham 
Polymers (Birmingham, AL).  Chitosan with >310 kDa MW and 85% degree of 
deacetylation, urea, Dulbecco’s modified Eagle medium (DMEM), lysozyme, glucose, 
sodium bicarbonate, and resazurin were obtained from Sigma Aldrich Chemical Co (St. 
Louis, MO).  A urea assay kit was obtained from Diagnostic Chemicals Limited (Oxford, 
CT).  Mouse embryonic fibroblasts (referred to as STO cell line) were purchased from 
American Tissue Culture Collection (Walkersville, MD).  L-glutamine, penicillin-
streptomycin, amphotericin, trypsin/EDTA, and Fetal Bovine Serum (FBS) were 
purchased from Invitrogen Corp. (Carlsbad, CA).   
Composite Layered Scaffold Fabrication 
 The composite structure is formed in layers as shown in Figure 7.  First, a Teflon 
sheet is affixed to a flat aluminum plate using silicon glue.  Teflon is used to provide a 
nonstick surface for the PLGA and the aluminum provides physical support to keep the 
Teflon flat.  A 6 cm x 8 cm well is formed on the Teflon sheet using silicon glue (see 
Figure 8A).  Five milliliters of 4% PLGA solution, prepared in chloroform, was poured 
into the well and air dried in a chemical hood overnight.  The silicon is trimmed away 
and the PLGA film is perforated with a custom punching apparatus.  The puncher 
consists of a Teflon grid marked in a 1 cm x 1 cm grid.  The PLGA film is placed on the 
grid and perforations are made using stainless steel nails and a hammer (see Figure 8B).  
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At this point some samples were analyzed under a light microscope in order to measure 
the perforation size (as described in the thickness characterization section below).  The 
perforated film is affixed to the Teflon sheet using silicon glue, forming another well.  
The well is filled with 10 mLs of 0.5% acidified chitosan solution, frozen at -80ºC, and 
lyophilized overnight.  After the silicon is removed again, the sample is flipped, and a 
new well formed with silicon glue.  Ten mL of chitosan solution is then added to the well, 
frozen at -80ºC and lyophilized overnight.  The silicon is removed and the samples are 
stored in a vacuum desiccator.  Before use, the composite membranes are neutralized in 
ethanol and washed with phosphate buffered saline (PBS). 
 
 




Step 1.  Dissolve PLGA in chloroform 
Step 3. Perforate PLGA layer with nails 
Step 4. Form chitosan matrix on one side 
Step 5. Form chitosan matrix on the other side 





Figure 8.  Construction of the Composite Scaffold  
Panel A.  Silicon glue is used to create a well for solvent casting.  Panel B.  The custom punching 







































 PLGA films were cast in Teflon wells as described, cut into small (2 mm) pieces, 
and oriented on a microscope slide so the cross section could be seen.  An image of the 
cross section was recorded using an inverted microscope and digital camera.  The cross 
section was then measured using Sigma Scan Pro software (Systat Software, Inc., Point 
Richmond, CA) which was calibrated using an image of a hemacytometer.  See 
Appendix 1 for more details. 
Uniaxial Mechanical Testing 
 To measure tensile properties the composite membranes were cut into 6 cm x 1 
cm strips and analyzed using an INSTRON 5842 (INSTRON Inc., Canton, MA) with a 
constant crosshead speed of 10 mm/min.  Tensile tests were performed at room 
temperature under hydrated conditions using a custom designed chamber.  See Appendix 
2 for more details. 
Analysis of Microarchitecture 
 To evaluate the microarchitecture of the matrices, samples were analyzed using a 
scanning electron microscopy (SEM, Joel scanning microscope).  For this purpose, 
samples were dehydrated using a series of increasing concentrations of ethanol followed 
by a brief vacuum drying. Samples were sputter coated with gold at 40 mA prior to 
observing under SEM.  See Appendix 3 for more details. 
Measurement of Permeability 
 Permeability was measured using a modified version of the method developed by 
Raghavan et al 36.  This method utilizes a custom designed chamber shown in Figure 10.  
The chamber’s diameter is 2 cm and each side has a holdup volume of 4 cm3.   The first 
chamber was filled with 550 mM urea in PBS.  The 550 mM concentration corresponds 
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to the average physiological concentrations present in human urine36.  A 2.5 cm x 2.5 cm 
section of the composite is placed on top of the solution, and the chamber is assembled.  
The other side of the sample (chamber 2) is filled with PBS using a syringe through the 
sample port.  The chamber was maintained at room temperature.  Small samples (100 L) 
were taken at regular intervals beginning after the chamber was assembled and 
continuing for 8 hours.  The concentration of urea was determined using a commercially 
available kit following the vendor’s protocols (Diagnostic Chemicals Limited, Oxford, 
CT). In brief, 20 L of sample was added to 2 mL of urease solution and the rate of 
change in absorption, at 340 nm, was measured for 90 s. The concentration of urea was 
determined using a calibration curve prepared between 0 to 275 mM urea. 
 












Sample Port Sample Port 
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Degradation Study 
 The degradation behavior of the composite scaffold was also examined. A 
degradation study was performed in standard 24-well cell culture plates using a modified 
procedure from Huang et al 95.  In brief, samples were cut into 1 cm x 1 cm pieces and 
placed into individual wells.  The samples were washed with ethanol, rinsed twice with 
PBS, and incubated at 37ºC in PBS containing 10 mg/L lysozyme.  The lysozyme 
containing PBS solution was changed every 7 days and the pH of the spent PBS was 
measured.  Samples were removed at 1, 3, 8, 14, 21, and 28 days, dehydrated in a 
graduated series of ethanol washes (0, 25, 50, 80, 100%), and weighed. The samples were 
then examined by SEM to evaluate changes in the microarchitecture as described before. 
Cell Culture 
 Mouse embryonic fibroblasts were grown in DMEM supplemented with 4 mM 
glutamine, 4.5 g/L glucose, 1.5 g/L sodium bicarbonate, 100 U/mL penicillin-
streptomycin, 2.5 mg/mL amphotericin B, and 10% Fetal Bovine Serum (FBS).  Cells 
were maintained at 37ºC, in a 5% CO2/95% air and fed with fresh medium every 48 h. 
Cells were dissociated with 0.01% trypsin / 10 mM EDTA, centrifuged, and resuspended 
in medium prior to cell seeding.  
 PLGA films, with and without perforations, 3D chitosan matrices, and the trilayer 
composite were prepared as described previously.  The samples were cut into 3 cm x 4 
cm pieces and placed in sterile 6 well cell culture plates.  The samples were sterilized by 
pure ethanol for 10 minutes and washed twice with PBS.  The PBS was replaced with cell 
growth media and the samples were seeded with 200,000 cells/sample.  The cells were 
allowed to grow for two days.  The samples were then examined with a light microscope 
to determine attachment of seeded cells.
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IV. Results
Composite Scaffold Physical Properties 
 One obstacle in fabricating the composite scaffolds was attaching the hydrophobic 
PLGA layer to the hydrophilic chitosan layer.  The solution was to perforate the PLGA 
layer and have the chitosan compartment run continuously through the resultant holes.  
The scaffolds were analyzed with SEM at all points of construction to ensure the 3D 
structural design elements were incorporated into the final scaffold.   
 The PLGA perforations were rectangular with sides between 300 and 550m long 
(Figure 11A).  The perforation size is determined by the size of the nail used. When a 
single chitosan layer has been added the porous chitosan can be seen through a 
perforation in the PLGA layer (Figure 11B).  This shows that there is good contact 
between the layers.  After a second layer of porous chitosan is added, micrographs show 
that the chitosan forms a continuous layer through the perforations (Figure 11C).   
Micrographs of the composite structure show all three distinct compartments and that the 
chitosan remains porous on both sides (Figure 11D).  The continuity of the chitosan is 
also supported by uneven areas on underside of composite membrane that follow the 
same pattern as the perforations. Additionally, the hydrated scaffold does not delaminate 
or come apart, further demonstrating that the composite is firmly anchored at the 
perforations. This data shows that the new fabrication process forms multi-layer 
composite scaffolds containing both natural and synthetic polymers. 
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 The thickness of the composite scaffolds is roughly 2mm, much larger than SIS 
(thickness 200m).  Using the custom Teflon-silicon well plates PLGA membranes were 
obtained with a thickness of 50 ± 16m.  Therefore, large thickness is a result of the 
surface tension and viscosity of the chitosan solution.  The chitosan solution has limited 
spreading on the hydrophobic PLGA film.   
 
Figure 11. Composite Scaffold Structure during Fabrication 
Panel A. SEM Micrograph of a perforation made in the PLGA film . Panel B. SEM Micrograph of a 
perforation in the 2 layer Chitosan-PLGA structure Panel C. SEM micrograph of the composite 
structure.   Panel D.  SEM micrograph showing that the porous chitosan layer is continuous through 













 An average thickness of the dry PLGA films (50 m) was used in the stress 
calculations of all materials PLGA films with and without perforations, and the 
composite.  The 50 m thickness was used in order to directly evaluate the effect of 
different processing steps on the tensile properties of PLGA.  Further, there were issues 
in accurately measuring the thickness in the composite structures.  At 4x magnification 
the entire scaffold is too large to visualize under the light microscope, the porous layer 
thickness varies when it is cut, and because the scaffold is soft it deforms when measured 
with a micrometer.  The composite structure has a break stress between 3.5 and 5 MPa 
which is comparable to the tensile stress of distal SIS (3MPa) 36 (Figure 12).  The stress 
strain curves are non-linear, and the composite structure stretches more than SIS before it 
breaks.   The stress strain curve for the composite also shows the point where the chitosan 
layer fails.  The small perturbations caused by the chitosan failure show that the majority 
of the composite scaffold’s mechanical strength comes from the PLGA layer.  The 
modulus of elasticity in the initial linear range (<80% strain) for the trilayer material is 
28.7 ± 7.6 KPa, and the modulus of elasticity for PLGA films is 12.8 ± 3.7 KPa.  The 
chitosan layers broke in a tiled pattern, and the chitosan tiles remained attached to the 
PLGA at the site of the perforations.  This can be seen as breaks in the stress strain curve 
(Figure 12).   
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Figure 12.  Stress Strain Behavior of SIS and Composite 
Permeability to Urea 
 The composite scaffold is much less permeable to urea than SIS.  After 8 hours, 
the final concentration of urea that had diffused through the composite is 80 mM while 
urea diffusing SIS reaches that concentration less than 30 minutes (Figure 13). 
Additionally, the 80 mM final concentration is only 30% of the expected equilibrium 
concentration of 275 mM, and after 8 hours the concentration of urea the initial side was 
approximately 300 mM.  When the data was fitted with trend lines the SIS data showed 
exponential growth to a maximum while the composite structure trend was a quadratic 
polynomial. 
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 Composite Scaffold  
 
Figure 13. Diffusion of Urea Across Composite Membrane 
 
Scaffold Degradation 
 To evaluate the degredation characteristics of the composite scaffolds, samples 
were incubated PBS containing in lysozyme, the enzyme that degrades chitosan.  These 
results showed no significant change in dimension when analyzed by SEM at different 
time points.  The composite scaffolds maintain both layered and porous structures during 
degradation (Figure 14).  This retention of structure is important because the layered 
structure provides mechanical strength to the composite and the porous structure 
enhances cellular growth.  The scaffolds showed minimal mass loss over 4 weeks 
(Figure 15).  Some of the losses were caused by the samples sticking to the well plates.  
Several samples proved difficult to remove.  The solution pH drops from 7.4 to 6.8 in one 
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day and remains steady at 6.8 for the next 7 days. This is caused by the PBS being 
incubated in a CO2 environment, as shown by a PBS control in Figure 16.   
 
Figure 14. Composite Membranes Retain their 3D Structure during Degradation 
Panel A. Cross Sectional View of the Composite Membrane after 3 days in PBS,  Panel B. Top View 
of the Composite Membrane after 3 days in PBS, Panel C. Cross Sectional View of the Composite 























Figure 15.  Mass Loss during the Degradation Experiment 
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Figure 16.   pH change during Degradation Experiment 
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Cell Culture 
 Data shows that cells will colonize the composite scaffold (Figure 17.)  Two days 
after cell seeding, many cells had attached to the tissue culture plastic (TCP) surfaces in 
wells containing PLGA (with and without perforations).  However, significantly fewer 
cells had attached to TCP surfaces in wells containing composite scaffolds. This indicates 
that the cells are attached to the composite membrane, but not to the PLGA film.   
 
Figure 17. Cells Attach to the Composite Membrane but not to PLGA 
Panel A. Cells adhere to the tissue culture plastic in well containing PLGA films with perforations. 













 This study explored the development of a novel process for generating composite 
scaffolds containing both natural and synthetic polymers.  Further, properties of the 
scaffolds were evaluated and compared to naturally occurring SIS.  The scaffolds were 
formed in a layered configuration consisting of a PLGA layer surrounded by two porous 
chitosan layers.  The hydrophobic PLGA layer was perforated and the hydrophilic 
chitosan layer was continuous through the perforations, anchoring the three layers 
together.  SEM micrographs show that the composite contains both the layered and 
porous structural elements.  Composite scaffolds have thicknesses on the order of 2 mm, 
ten times the thickness of SIS.  The increased thickness is due to the chitosan solution 
pooling on the hydrophobic PLGA.   
 The composite has mechanical properties similar to SIS 36.  It exhibits non-linear 
behavior and has a tensile stress greater than SIS.  The PLGA layer retains its mechanical 
strength in a composite scaffold, and remains mechanically sound under tensile loading.  
The composite does not delaminate with the chitosan layers remaining firmly anchored at 
the perforations. 
 The composite also proved to be less permeable to urea than SIS 36.  Over 8 hour 
contact times the final concentration of urea that has diffusing through the composites is 
80 mM while in SIS urea reaches similar concentrations in only 30 minutes.  This is 
beneficial because a less permeable scaffold will leak less nitrogenous waste into 
surrounding tissues. 
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 Over the course of 4 weeks, composite scaffold degradation was minimal.  pH 
profiles during degradation experiments match profiles for the PBS control, 
demonstrating that the composite scaffold does not leach acidic byproducts.  The 
composite scaffold retains both the layered and porous structural elements throughout the 
degradation run.  
 The composite scaffolds show good potential for cell colonization.  Two days 
after cell seeding, many cells had attached to the tissue culture plastic (TCP) surfaces in 
wells containing PLGA (with and without perforations).  However, significantly fewer 
cells had attached to TCP surfaces in wells containing composite scaffolds. This shows 
that cells attach to the composite structure more readily than to PLGA films. 
 The composite scaffold shows significant potential for use in tissue engineering 
applications. The composite contains both layered and porous structural features and 
provides suitable mechanical properties.  The scaffold is relatively impermeable to urea.  
The composite demonstrates the capacity for cell colonization and the potential for cell 
growth. 
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VI. Recommendations and Future Directions
 In light of current successes, the next phase of the project should focus on, 
modifying the process for use in other polymer systems, increasing the biological activity 
of the composite, modeling mass transfer through the scaffold, and utilizing the process 
as a platform technology to create custom multilayer scaffolds for a variety of tissue 
engineering applications.  These studies continue the process toward the overall goal of 
generating a patentable material, approved by the FDA, for improved treatment of 
bladder defects and diseases. 
 The scaffold physical properties should be examined further.  Since the majority 
of the biological loading is cyclical, cyclic tests should be performed to measure and 
model the viscoelastic properties of the composite.  The effect of the perforations should 
also be investigated.  The effect of both perforation size and spacing on the composite’s 
physical properties should be investigated.  Permeability studies should be conducted to 
determine if the permeability is primarily controlled by the number of perforations, the 
thickness and porosity of the chitosan layer, or both. Also, the degradation kinetics of the 
composite scaffold should be investigated further, including a long term degradation 
study and changes in scaffold dimensions during degradation.  Further studies should be 
conducted to exploring methods to decrease the thickness of the composite.  Reducing the 
hydrophobicity of the PLGA layer through nano-etching with a base47 or decreasing the 
surface tension of the chitosan solution with detergents (SDS, Triton-X 100).  
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Additionally, the scaffold thickness could be made more uniform by adding a final 
pressing step to the process. 
 The method of composite scaffold construction is not limited solely to the PLGA 
and chitosan system.  The central polymer film can be created by any desired method, 
and the outer layers can be added provided the solvent does not dissolve the central layer.  
Additional studies utilizing other polymers (PCL, PLA, PGA, gelatin, etc) should be 
performed to analyze the effectiveness of this method as a platform technology.  For 
example, a scaffold containing low molecular weight PCL and gelatin would provide 
faster degradation.  Scaffolds containing PCL and a blend of chitosan and gelatin could 
possibly improve bioactivity.  It may also be possible to form a two layer asymmetric 
matrix using a PCL and chitosan.  Additionally, PCL membranes can be constructed in 
non-planar geometries using techniques developed in our laboratory by others (data 
unpublished).  Ideally, the system will be adapted to produce spherical scaffolds.   
Standard photolithographic methods could also be used to fabricate composite scaffolds.  
Photolithography will enable more precise control of the perforation pattern and scaffold 
micro-structure.  Additionally, photolithographic techniques have already been developed 
for industrial scale processing.  Biological activity could be enhanced by using either 
gelatin or blended chitosan/gelatin hydrogels instead of the 3D porous chitosan. 
 This study explored cellular adhesion and short term cell viability.  The study 
needs to be expanded to include long term viability and quality of the remodeled tissue.  
Additionally, the composite should be optimized to increase its biological activity.  The 
composite should be seeded with smooth muscle cells, and then analyzed for cellular 
growth, proliferation, and organization.  The multilayer design also shows the potential to 
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grow multiple tissue layers simultaneously.  Smooth muscle cells may be seeded onto one 
side of the composite while urothelial cells are seeded on the other.  The central layer 
should provide a barrier between the two tissue compartments, preventing ingrowth of 
one cell type into the other until both regenerated tissues have time to organize 
themselves.  Degradable nano-particles may be incorporated within the scaffold in order 
to release growth factors.  These growth factors can also be incorporated into either a 
central PLGA layer or outer hydrogels layers and their release will be controlled by the 
degradation rate of the composite.  The system may be applicable for the regeneration of 
other heterogeneous tissues. 
 The system should be modeled to determine the mass transfer coefficients for 
both Urea and oxygen.  After optimizing scaffold construction scale up and mass 
production issues will have to be addressed. A bioreactor experiment should be 
performed to model the transport of both oxygen and urea across the scaffold.  Then 
using the mass transfer coefficient the system can be simulated, including oxygen 
consumption, in order to evaluate and optimize a variety of spherical bioreactor designs. 
 This research shows great potential to expand the realm of tissue engineering.  In 
time they may lower the demand for donor tissues and organs, and these studies should 
help improve the treatment of bladder defects and diseases. 
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Appendix 1: Measuring PLGA Layer Thickness
 The thickness of the PLGA layer was measured by first cutting the samples into 2 
mm x 10 mm pieces.  The pieces were placed on a glass microscope slide so the cross 
section was visible under an inverted microscope.   A .jpg image was captured and 
imported into Sigma Scan Pro software.    The length scale is set using a two point 
calibration on a hemocytometer (See Figure 18, the small squares have 250m sides).  
Then the flim thickness can be measured as shown in Figure 19.  Sample data for 
thickness measurements for membranes formed in Petri dishes and custom made square 
wells are shown in Table 1 and Table 2.  
 











(um)  Point 
Thickness 
(um)  Point 
Thickness 
(um) 
1 70.6  16 65.27  32 61.55 
2 71.57  17 67.09  33 55.99 
3 68.71  18 62.5  34 56.39 
4 67.81  19 62.98  35 66.07 
5 68.31  20 67.62  36 58.67 
6 69.17  21 67.17  37 61.72 
7 61.1  22 81.31  38 60.19 
8 61.66  23 67.17  39 58.21 
9 66.68  24 68.8  40 60.56 
10 65.91  25 68.38  41 59.77 
11 56.49  26 69.4  42 60.56 
12 63.73  27 62.32  43 58.2 
13 61.55  28 69.73  44 57.96 
14 68.89  29 57.83  45 58.99 
15 72.5  30 55.98  46 56.93 
   31 59.69    
        
Average 66.8     
Standard Deviation 4.9     
Table 1. Sample Thickness Data for Teflon Petri Dishes 
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Sample Measurement Thickness (um)  Sample Measurement Thickness (um) 
1 1 51  10 1 40.4 
1 2 49  10 2 35.3 
1 3 50.8  10 3 34.5 
1 4 52.2  10 4 30 
1 5 49.9  10 5 35.9 
2 1 54  11 1 38.8 
2 2 53.9  11 2 47 
2 3 52.4  11 3 41.8 
2 4 49  11 4 45.4 
2 5 49.1  11 5 41.8 
3 1 41.2  12 1 39.3 
3 2 40.2  12 2 39.3 
3 3 36.5  12 3 46 
3 4 44.6  12 4 51.9 
3 5 41.7  12 5 43.1 
4 1 43.5  13 1 33.1 
4 2 39.9  13 2 34.6 
4 3 37.6  13 3 33.1 
4 4 40.4  13 4 34.1 
4 5 34.5  13 5 36.2 
5 1 51.1  14 1 52.3 
5 2 47.5  14 2 58.9 
5 3 50.8  14 3 70.5 
5 4 47.4  14 4 81.7 
5 5 47.6  14 5 88.3 
6 1 40.9  15 1 50.5 
6 2 46.2  15 2 54.1 
6 3 43.5  15 3 52.1 
6 4 40.8  15 4 53.5 
6 5 39.5  15 5 51.1 
7 1 49  16 1 96.7 
7 2 51.7  16 2 97.1 
7 3 54.6  16 3 91.3 
7 4 54.7  16 4 84.1 
7 5 54.6  16 5 94.3 
8 1 40.4  17 1 93.1 
8 2 38.2  17 2 78.4 
8 3 39.5  17 3 67 
8 4 34.3  17 4 47.4 
8 5 39  17 5 39.2 
9 1 29.2  18 1 45.1 
9 2 27.7  18 2 39.3 
9 3 30  18 3 33.5 
9 4 30.7  18 4 37 
9 5 30.1  18 5 32.3 
Table 2.  Sample Thickness Data using Custom Teflon-Silicon Wells 
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Sample Measurement Thickness (um) 
19 1 34.7 
19 2 38.1 
19 3 34.7 
19 4 39.3 
19 5 39.3 
   
Average 42.9 
Standard Deviation 7.8 
Table 3.  Sample Thickness Data using Custom Teflon-Silicon Wells
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Appendix 2: Stress-Strain Calculations and Data
 Stress-strain measurements were taken in a hydrated condition using a custom 
designed chamber filled with PBS (Figure 20).  Hydrated samples were cut into 1 cm x 6 
cm sections, centered in the hydraulic grips (Figure 21), and pulled at a constant 
crosshead speed of 10mm/min.  In order to directly compare the material the average 
PLGA film thickness (50m) was used for all stress calculations.  Sample data for PLGA 
films, perforated PLGA films, and the composite scaffold is shown in Table 4, Table 5, 
and Table 6. 
 
Figure 20. Custom Liquid Chamber used to Perform Mechanical Tests 
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% MPa  % MPa  % MPa 
Every Data Point 
Shown  
Every Data Point 
Shown  
Every Data Point 
Shown 
0.8 0.02  19.1 3.14  34.8 1.28 
1.6 0.05  19.8 3.33  35.0 0.99 
2.4 0.08  20.6 3.50  35.2 0.71 
3.2 0.12  21.4 3.64  35.3 0.43 
4.0 0.18  22.2 3.73  36.1 0.19 
4.8 0.24  23.0 3.77  36.9 0.18 
5.6 0.31  23.8 3.73  37.7 0.17 
6.4 0.39  24.6 3.64  38.5 0.18 
7.1 0.49  25.4 3.60  39.3 0.18 
7.9 0.60  26.2 3.58  40.1 0.17 
8.7 0.72  27.0 3.58  40.9 0.18 
9.5 0.86  27.8 3.60  41.7 0.18 
10.3 1.01  28.6 3.57  42.5 0.18 
11.1 1.17  29.4 3.57  43.3 0.18 
11.9 1.34  30.2 3.49  44.1 0.18 
12.7 1.52  31.0 3.35  44.9 0.18 
13.5 1.72  31.7 3.12  45.7 0.19 
14.3 1.92  32.5 2.97  46.4 0.19 
15.1 2.13  33.2 2.69  47.2 0.19 
15.9 2.33  33.8 2.41  48.0 0.19 
16.7 2.54  34.2 2.13  48.8 0.19 
17.5 2.74  34.4 1.84  49.6 0.16 
18.3 2.95  34.7 1.56  50.4 0.14 




Stress  Distal Strain 
Distal 
Stress  Distal Strain 
Distal 
Stress 
% Mpa  % Mpa  % Mpa 
Every 5th Data Point 
Shown  
Every 5th Data Point 
Shown  
Every 5th Data Point 
Shown 
4.2 0.02  53.4 4.99  89.9 0.25 
8.1 0.07  54.2 5.04  93.9 0.22 
12.1 0.19  58.1 5.06  97.9 0.26 
16.1 0.42  62.0 4.43  98.7 0.26 
20.0 0.77  65.3 3.82  102.6 0.29 
20.8 0.85  69.3 3.27  106.6 0.06 
24.8 1.33  69.8 3.09  110.6 0.05 
28.8 1.91  71.3 2.19  114.5 0.06 
32.7 2.58  74.2 1.29  115.3 0.07 
36.7 3.27  77.2 0.58  119.3 0.09 
37.5 3.41  81.2 0.38  123.3 0.12 
41.5 4.07  82.0 0.39  127.2 0.17 
45.4 4.62  86.0 0.35  131.2 0.04 
49.4 4.91     132.0 0.04 











% Mpa  % Mpa 
Every 10th Data Point Shown  Every 10th Data Point Shown 
0 0.01  157 3.13 
5 0.14  162 3.20 
10 0.30  164 3.23 
13 0.39  169 3.30 
18 0.56  174 3.36 
23 0.76  177 3.39 
25 0.86  182 3.45 
30 1.10  187 3.48 
35 1.31  189 3.50 
38 1.42  194 3.48 
43 1.60  199 3.48 
48 1.76  202 3.49 
51 1.82  207 3.51 
56 1.95  212 3.52 
61 2.07  215 3.54 
63 2.11  220 3.56 
68 2.16  225 3.55 
73 2.21  227 3.57 
76 2.25  232 3.59 
81 2.31  237 3.61 
86 2.38  240 3.63 
88 2.40  245 3.65 
93 2.46  250 3.68 
98 2.51  253 3.69 
101 2.54  258 3.73 
106 2.59  263 3.76 
111 2.63  265 3.76 
114 2.66  270 3.53 
119 2.70  275 3.56 
124 2.74  278 3.58 
126 2.77  283 3.61 
131 2.81  288 3.63 
136 2.86  290 3.64 
139 2.89  295 3.66 
144 2.94  301 3.68 
149 3.02  303 3.70 
152 3.06  308 3.72 
   313 3.75 
Table 6.  Sample Stress-Strain Data for the Composite Scaffold
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Appendix 3: Scanning Electron Microscope
Sputter Coat the Sample with Gold 
1. Apply a small coating of colloidal graphite to a clean stub 
2. Place sample on carbon coating and let dry 
3. Open the sputter coater chamber, insert stubs, and close chamber 
4. Turn on the argon gas cylinder (counter-clockwise) 
5. Turn on sputter coater and force down the lid to ensure a good seal 
6. Push the “Manual” button 
7. Wait for vacuum pressure to reach 0.02 mbar (takes 5 - 10 min) 
8. Activate “Flush” for five seconds 
9. Activate “Leak” for five seconds 
10. Wait for pressure to reach 0.05 mbar 
11. Press “Start” and allow coating for 30 - 60 seconds (To set time hold down 
pause/test button and use arrow keys) 
12. Turn power off and close argon gas cylinder  
13. Open the nitrogen gas cylinder to remove vacuum 
14. Close nitrogen cylinder and remove stub 
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Operating the Scanning Electron Microscope 
1. Open cooling water valve 
2. Turn on computer and open SEM main menu 
3. Go to the “Sample” menu and click “Vent” 
4. When the vent light stops flashing, open the SEM chamber and insert the sample 
5. Close chamber and press “Evac”  
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